General Manager (Australia) and Director, Science & Technology
Kailing Wang obtained her PhD in biochemistry at the University of Sydney in 1997, followed by post-doctoral training at the University of Sydney and the Victor Chang Cardiac Research Institute. She has over 15 years of medical research experience in the field of protein biochemistry, molecular biology, cell biology and virology. She worked for Gradipore, then Life Therapeutics from 2000 till 2006 and returned to NuSep and PrIME Biologics in 2011. She has accumulated extensive hands-on R&D experience in membrane electrophoresis technology development, application development and viral/TSE clearance studies in plasma fractionation. Prior to joining NuSep Ltd, she was a Business Development Manager at the University of Sydney where she was responsible for developing commercialisation opportunities across research translation continuum.